[EXPERIMENTS]
50% fewer

Reduction in required experiments through factorial and response surface designs versus one-factor-at-a-time approaches.

[DEVELOPMENT]
faster

Accelerated formulation development cycles by simultaneously investigating multiple factors and their interactions.

[GMP]
GMP validated

Full GMP audit compliance with ALCOA+ data integrity, change control, and documentation for regulatory submission.

Design of Experiments
PHARMACEUTICAL

Pharmaceutical
Design of Experiments

Pharmaceutical development demands GMP-validated experimental design to optimise drug formulations, coating parameters, and dissolution profiles. Our DOE methodology delivers statistically robust results that satisfy regulatory requirements while accelerating product development timelines.

[INDUSTRY_CHALLENGES]

DOE Challenges
in Pharmaceuticals

Regulatory compliance, formulation complexity, and batch consistency drive pharmaceutical DOE needs.

Drug Formulation Optimisation

Pharmaceutical formulations involve complex interactions between excipients, active ingredients, and processing conditions. DOE systematically identifies optimal combinations that maximise bioavailability and stability.

Tablet Coating Parameters

Film coating quality depends on spray rate, inlet temperature, pan speed, and coating solution viscosity. DOE determines the critical parameters and their optimal levels for uniform coating.

Dissolution Rate Analysis

Dissolution profiles must meet strict regulatory specifications. DOE investigates the factors controlling dissolution rate to achieve consistent, reproducible release profiles.

GMP Documentation Requirements

All experimental work must be fully documented to GMP standards. Our DOE methodology includes complete audit trails, change control, and traceability for regulatory submissions.

[DOE_PROCESS]

Our 8-Step
DOE Framework

A GMP-validated 8-step DOE methodology for pharmaceutical process and formulation optimisation.

01

Planning

Define clear objectives, success criteria, and measurable KPIs that align the experiment with your broader engineering and business goals.

Identify all relevant factors and their operational levels, establish measurement system reliability through Gauge R&R studies, and define statistical control boundaries. A robust plan ensures resources are allocated efficiently and that every test run produces actionable data.

02

Screening

Run targeted preliminary experiments to separate the critical few factors from the trivial many, drastically reducing experimental scope.

Leverage Fractional Factorial, Plackett-Burman, or Definitive Screening Designs to evaluate dozens of potential variables in a fraction of the runs a full factorial would require. The deliverable is a ranked Pareto chart of factor significance, enabling your team to focus on the variables that truly drive performance.

03

Modelling

Construct a rigorous mathematical model that quantifies how significant factors and their interactions drive your response variable.

Apply Full Factorial or Response Surface designs to capture main effects, two-way interactions, and curvature. The resulting model is validated with ANOVA, residual diagnostics, and R-squared metrics to ensure it reliably predicts system behaviour across the design space.

04

Optimisation

Fine-tune factor settings using response surface methodology to pinpoint the operating conditions that maximise yield, quality, or efficiency.

Deploy Central Composite or Box-Behnken Designs to map the response surface and locate global optima, even in the presence of complex factor interactions. Multi-objective optimisation techniques such as desirability functions are applied when balancing competing performance targets.

05

Verification

Execute confirmation runs under the predicted optimal conditions to validate that the model accurately reflects real-world process behaviour.

Compare observed responses against model predictions using confidence and prediction intervals to assess agreement. If deviations exceed acceptable thresholds, the model and optimisation parameters are iteratively refined until robust, repeatable performance is confirmed.

06

Execution

Carry out each experimental run according to the randomised design matrix, maintaining strict control over environmental conditions and procedural consistency.

All relevant process parameters, environmental readings, and response measurements are recorded in structured data logs with full traceability. Randomisation and blocking strategies are enforced to guard against systematic bias, ensuring the collected dataset is statistically sound.

07

Analysis

Apply statistical analysis — including ANOVA, effect plots, and contour maps — to extract meaningful patterns, interactions, and correlations from the experimental data.

Beyond classical statistics, advanced predictive models are built using neural networks (SANN), machine learning algorithms, and AI-driven pattern recognition. These complementary techniques uncover non-linear relationships that traditional regression may miss, delivering deeper process understanding.

08

Utilisation

Translate experimental insights into concrete process improvements, updated specifications, and operational best practices that drive measurable business value.

A comprehensive report documenting the experimental design, statistical findings, and recommended operating windows is delivered to all stakeholders. Knowledge is embedded into SOPs, control plans, and continuous improvement frameworks to ensure long-term retention and replication across projects.

[DELIVERABLES]

What You
Receive

GMP-compliant DOE deliverables for pharmaceutical development and regulatory submissions.

Experimental Design Report

Full factorial, fractional factorial, or response surface design with rationale, factor selection, and statistical power analysis.

Statistical Analysis Package

ANOVA tables, main effects plots, interaction plots, and response surface contour maps with confidence intervals.

Optimisation Results

Optimal factor settings with predicted response values, desirability functions, and confirmation run requirements.

Predictive Model

Validated mathematical model relating factors to responses, with R² values and prediction intervals for process control.

GMP Documentation Package

Protocol, raw data, analysis records, and summary report formatted for regulatory submission and audit readiness.

Design Space Definition

Operating ranges for critical process parameters with proven acceptable ranges for Quality by Design submissions.

[EXPECTED_OUTCOMES]

Proven Results in
Pharmaceuticals

Based on DOE projects across solid dosage, liquid formulations, and bioprocessing applications.

50%
Fewer experiments needed
100%
GMP audit compliance
Faster development cycles
[PHARMA_FAQ]

Pharmaceutical
DOE FAQ

Common questions about Design of Experiments in pharmaceutical development.

GET STARTED

Ready to
Optimise?

Our pharmaceutical DOE specialists deliver GMP-validated experimental design for your formulation and process development.

  • Systematic multi-variable optimisation
  • Pharmaceutical-specific DOE methodology
  • AI & ML-powered predictive modelling
Response Time
Next Working Day

Request Pharmaceutical DOE

Fill out the form below. * Required fields